Exelixis (EXEL) is down -12.5%, or -$4.89 to $34.36.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXEL:
- Morning Movers: Cleveland-Cliffs surges following earnings report
- Exelixis’s Zanza: A Strong Contender with Promising Survival Rates and Manageable Safety Profile
- Exelixis reports detailed results from STELLAR-303
- Exelixis announces results from analysis of CABINET Phase 3 trial of CABOMETYX
- Exelixis: Buy Rating Backed by Strategic Positioning and Growth Prospects